Head to Head Review: Utah Medical Products (UTMD) versus Neogen (NEOG)
Neogen (NASDAQ: NEOG) and Utah Medical Products (NASDAQ:UTMD) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.
This is a breakdown of current recommendations and price targets for Neogen and Utah Medical Products, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Utah Medical Products||0||0||0||0||N/A|
Volatility and Risk
Neogen has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500.
Utah Medical Products pays an annual dividend of $1.06 per share and has a dividend yield of 1.4%. Neogen does not pay a dividend. Utah Medical Products pays out 30.4% of its earnings in the form of a dividend.
This table compares Neogen and Utah Medical Products’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Utah Medical Products||32.98%||17.91%||15.95%|
Institutional and Insider Ownership
86.1% of Neogen shares are held by institutional investors. Comparatively, 66.8% of Utah Medical Products shares are held by institutional investors. 4.2% of Neogen shares are held by company insiders. Comparatively, 9.1% of Utah Medical Products shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Earnings & Valuation
This table compares Neogen and Utah Medical Products’ top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Neogen||$373.21 million||7.93||$81.51 million||$1.19||65.05|
|Utah Medical Products||$39.60 million||7.07||$20.09 million||$3.49||21.56|
Neogen has higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than Neogen, indicating that it is currently the more affordable of the two stocks.
Neogen beats Utah Medical Products on 7 of the 13 factors compared between the two stocks.
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the production and marketing of products dedicated to animal health, including a range of consumable products marketed to veterinarians and animal health product distributors. The Animal Safety segment also provides genetic identification services. Additionally, the Animal Safety segment produces and markets rodenticides, disinfectants and insecticides to assist in the control of rodents and disease in and around agricultural, food production and other facilities.
About Utah Medical Products
Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. UTMD markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit, the labor and delivery department and the women’s health center in hospitals, as well as products sold to outpatient clinics and physician’s offices.
Receive News & Ratings for Neogen Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen Co. and related companies with MarketBeat.com's FREE daily email newsletter.